{"brief_title": "Lethargic Depression Study", "brief_summary": "This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.", "detailed_description": "A Multicenter, Double-Blind, Placebo-controlled comparison of the efficacy and safety of flexible dose extended-release bupropion (HCl) 300-450 mg/day and placebo administered for eight weeks for the treatment of adult outpatients with major depressive disorder including symptoms of decreased energy, pleasure, and interest", "condition": ["Epilepsy", "Major Depressive Disorder (MDD)"], "intervention_type": ["Drug"], "intervention_name": ["Extended-release bupropion (HCl)"], "criteria": "Inclusion criteria: - Primary diagnosis of MDD with current duration lasting 12 weeks but no greater than 2 years. - Generally in good health. - Subject must read and write at a level sufficient to provide written informed consent. Exclusion criteria: - Current or past history of seizure disorder. - Subject has a primary diagnosis or received treatment for panic disorder, obsessive compulsive disorder (OCD), post traumatic stress disorder (PTSD), acute stress disorder, Bipolar I or II disorder, schizophrenia, or other psychotic disorder. - Currently using illicit drugs or other psychotropic drugs. - Patient poses a current suicidal risk or has attempted suicide in the past 6 months.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "depression", "mesh_term": ["Depressive Disorder", "Depression", "Depressive Disorder, Major", "Lethargy", "Bupropion"], "id": "NCT00064467"}